Nicotinate phosphoribosyltransferase (NAPRT) (N-Term) Peptide
-
- Target See all NAPRT1 (NAPRT) products
- NAPRT1 (NAPRT) (Nicotinate phosphoribosyltransferase (NAPRT))
- Protein Region
- N-Term
- Origin
- Human, Mouse
-
Source
- Synthetic
- Application
- Blocking Peptide (BP), Western Blotting (WB)
- Sequence
- RLIAGPDKKL LEMGLRRAQG PDGGFTASIY SYLGGFDSSS NTLAGQLRGV
- Characteristics
- This is a synthetic peptide designed for use in combination with anti-Naprt1 Antibody. It may block above mentioned antibody from binding to its target protein in western blot and/or immunohistochecmistry under proper experimental settings. There is no guarantee for its use in other applications.
- Purification
- Purified
-
-
- Application Notes
- Each Investigator should determine their own optimal working dilution for specific applications.
- Restrictions
- For Research Use only
-
- Format
- Lyophilized
- Reconstitution
- Add 100 μL of sterile PBS. Final peptide concentration is 1 mg/mL in PBS.
- Concentration
- 1 mg/mL
- Buffer
- Final peptide concentration is 1 mg/mL in PBS.
- Handling Advice
- Avoid repeated freeze-thaw cycles.
- Storage
- -20 °C
- Storage Comment
- For longer periods of storage, store at -20°C. Avoid repeat freeze-thaw cycles.
-
- Target
- NAPRT1 (NAPRT) (Nicotinate phosphoribosyltransferase (NAPRT))
- Background
-
Naprt1 catalyzes the conversion of nicotinic acid (NA) to NA mononucleotide (NaMN). It is essential for NA to increase cellular NAD levels and prevent oxidative stress of the cells.
Alias Symbols: 9130210N20Rik
Protein Size: 538 - Molecular Weight
- 58 kDa
- Gene ID
- 223646
- NCBI Accession
- NM_172607, NP_766195
- UniProt
- Q8CC86
-